M4MM

Willow Biosciences Posts Record Revenue in Q2

LOS ANGELES- Willow Biosciences Inc. a synthetic biology company specializing in pharmaceutical ingredients, reported record revenue of $1 million for the second quarter of 2024, a 660% increase compared to the same period last year. ...

Week’s In Review: Federal Policy Uncertainty Continues to Challenge U.S. Cannabis Industry; LeafLink Acquires Leaf Trade to Enhance Cannabis Wholesale Platform; Canopy Growth Appoints New CEO Amid Financial Challenges; New York’s Legal Cannabis Sales Approach $1 Billion Milestone

LOS ANGELES — Welcome to the far too-exciting world of cannabis and psychedelics, where it’s a tale of two markets with some states doing amazingly well. And some, well...they're not doing so well (hello New ...

  • NuLeaf Family Oil

NuLeaf Naturals Earns B Corp Certification

DENVER -- NuLeaf Naturals, makers of cannabinoid products announced, it has earned B Corporation™ certification. A pioneer in the CBD industry, NuLeaf Naturals joins an elite group of for-profit companies building a more sustainable and ...

  • Panaxia Pharmaceutical Industries

Panaxia Continues Growth

LOD, Israel -- Panaxia Labs Israel Ltd., (TASE: PNAX), a pharma company that develops, manufactures and markets progressive medical cannabis products in pharmaceutical quality, published its financial reports for the second quarter and first half ...

France Medical Cannabis Patient Program Gets Underway

EDMONTON, AB– Aurora Germany GmbH, a subsidiary of Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, and Ethypharm, have successfully delivered their initial shipment of cannabis to the ...

Greenlane Shareholders Vote to Approve Merger with KushCo

BOCA RATON–Greenlane Holdings, Inc. (Nasdaq: GNLN), a global house of brands and one of the largest sellers of premium cannabis accessories, child-resistant packaging, and specialty vaporization products, today announced that its stockholders have approved the ...

Subscribe To Our Newsletter